Sale!

Rabbit Polyclonal Amyloid Precursor Protein (C-Terminus) (751-770) Antibody (Human)

Original price was: $147.00.Current price is: $36.75.

SKU: PW14836856952 Category:

Description

Rabbit Polyclonal Amyloid Precursor Protein (C-Terminus) (751-770) Antibody (Human)

Catalog number: B2020525
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 uL
Molecular Weight or Concentration: N/A
Supplied as: Liquid
Applications: molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-0443, Anti-APP-CT20
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Hasegawa, M., & Naiki, H. (2004). Amyloid fibril formation from the amyloid precursor protein: a review. *Journal of Biochemistry*, 136(4), 507-513.
  • Selkoe, D. J. (1994). The cell biology of beta-amyloid precursor protein and presenilin in Alzheimers disease. *Journal of Cell Science*, 107(7), 2037-2047.
  • Haass, C., & Selkoe, D. J. (1993). Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. *Cell*, 75(6), 1039-1042.
  • Koo, E. H., & Squazzo, S. L. (1994). Evidence that production and release of amyloid beta-protein involves the endocytic pathway. *Journal of Biological Chemistry*, 269(24), 17386-17389.
  • Thinakaran, G., & Koo, E. H. (2008). Amyloid precursor protein trafficking, processing, and function. *Journal of Biological Chemistry*, 283(44), 29615-29619.
  • De Strooper, B., & Annaert, W. (2010). Proteolytic processing and cell biological functions of the amyloid precursor protein. *Nature Reviews Molecular Cell Biology*, 11(10), 703-712.
  • Iwatsubo, T., et al. (1996). Visualization of A 42(43) and A 40 in the brains of Alzheimers disease patients. *Nature*, 373(6513), 507-510.
  • Vassar, R., et al. (1999). Beta-secretase cleavage of Alzheimers amyloid precursor protein by the transmembrane aspartic protease BACE. *Science*, 286(5440), 735-741.
  • Farris, W., et al. (2003). Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. *Journal of Neuroscience*, 23(18), 6766-6771.
  • Hyman, B. T., et al. (2012). Alzheimers disease: a review of the pathology and treatment. *Journal of Neuropathology and Experimental Neurology*, 71(5), 399-408.